What's Happening?
Natera has integrated its oncology testing portfolio with Flatiron Health's OncoEMR platform, allowing seamless electronic ordering and results delivery for cancer care providers. This integration aims to streamline the clinical workflow for over 4,500
providers, enhancing the efficiency of molecular residual disease testing and monitoring.
Why It's Important?
The integration of Natera's testing with Flatiron Health's platform represents a significant advancement in precision medicine and oncology care. By simplifying the ordering and results process, healthcare providers can access critical insights more quickly, potentially improving patient outcomes. This collaboration underscores the importance of technology in modernizing healthcare delivery and supporting evidence-based treatment decisions.
